These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 23474621)
1. Bioabsorbable scaffolds for the treatment of obstructive coronary artery disease: the next revolution in coronary intervention? Patel N; Banning AP Heart; 2013 Sep; 99(17):1236-43. PubMed ID: 23474621 [TBL] [Abstract][Full Text] [Related]
2. Looking into the future with bioresorbable vascular scaffolds. Costopoulos C; Naganuma T; Latib A; Colombo A Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1407-16. PubMed ID: 24138526 [TBL] [Abstract][Full Text] [Related]
4. Bioresorbable Stents: Is This Where We Are Headed? Wayangankar SA; Ellis SG Prog Cardiovasc Dis; 2015; 58(3):342-55. PubMed ID: 26319497 [TBL] [Abstract][Full Text] [Related]
5. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent. Waksman R; Pakala R EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674 [TBL] [Abstract][Full Text] [Related]
6. Bioabsorbable drug-eluting stents: the future of coronary angioplasty? Macaya C; Moreno R Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):598-9. PubMed ID: 18679382 [TBL] [Abstract][Full Text] [Related]
8. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy. Wykrzykowska JJ; Onuma Y; Serruys PW EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680 [No Abstract] [Full Text] [Related]
9. Bioresorbable vascular scaffolds in left main coronary artery disease. Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148 [TBL] [Abstract][Full Text] [Related]
10. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495 [TBL] [Abstract][Full Text] [Related]
11. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives. Kitabata H; Waksman R; Warnack B Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760 [TBL] [Abstract][Full Text] [Related]
12. Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective. Kraak RP; Grundeken MJ; Koch KT; de Winter RJ; Wykrzykowska JJ Expert Rev Med Devices; 2014 Sep; 11(5):467-80. PubMed ID: 25087771 [TBL] [Abstract][Full Text] [Related]
14. What about the risk of thrombosis with bioresorbable scaffolds? Capodanno D; Joner M; Zimarino M EuroIntervention; 2015; 11 Suppl V():V181-4. PubMed ID: 25983162 [TBL] [Abstract][Full Text] [Related]
15. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography. Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418 [No Abstract] [Full Text] [Related]
20. Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds? Bangalore S; Mauri L EuroIntervention; 2009 Dec; 5 Suppl F():F43-8. PubMed ID: 22100675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]